Gapping down
In reaction to earnings/guidance:
- CDK -8.6%, PLCE -8.5%, CREE -5.4% (also expands silicon carbide wafer supply agreement with STM), VTEX -5.2%, CRMT -2.6%, ADI -2.6%, TGT -1.8%, JKHY -1.1%, AMCR -0.8%, EAT -0.8%
Other news:
- PFMT -10% (prices offering of 10.525 mln shares of common stock at $3.80 per share)
- MRNS -3.4% (receives orphan drug designation from FDA; reports top-line results from Phase 2 trial of ganaxolone in tuberous sclerosis complex)
Analyst comments:
- ORTX -4.9% (downgraded to Neutral from Overweight at JP Morgan)
- FCPT -1.1% (downgraded to Outperform from Strong Buy at Raymond James)
- STOR -1% (downgraded to Mkt Perform from Outperform at Raymond James)
- AMCR -0.8% (downgraded to Sell from Neutral at Goldman)